(Q48312407)

10 February 2018

title

Amplification of gene expression using both 5'- and 3'-untranslated regions of GLUT1 glucose transporter mRNA. (English)

1 reference

10 February 2018

author

William M Pardridge

series ordinal

2

1 reference

10 February 2018

author name string

Boado RJ

series ordinal

1

1 reference

10 February 2018

publication date

1 January 1999

1 reference

10 February 2018

published in

Molecular Brain Research

1 reference

10 February 2018

volume

63

1 reference

10 February 2018

issue

2

1 reference

10 February 2018

page(s)

371-374

1 reference

10 February 2018

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900280-0

1 reference

7 January 2021

Expression from leukocyte integrin promoters in retroviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900280-0

7 January 2021

T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900280-0

7 January 2021

Brain-derived peptides increase the expression of a blood-brain barrier GLUT1 glucose transporter reporter gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900280-0

7 January 2021

Glucose deprivation causes posttranscriptional enhancement of brain capillary endothelial glucose transporter gene expression via GLUT1 mRNA stabilization.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900280-0

7 January 2021

The 5'-untranslated region of GLUT1 glucose transporter mRNA causes differential regulation of the translational rate in plant and animal systems.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900280-0

7 January 2021

Gene expression of GLUT3 and GLUT1 glucose transporters in human brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900280-0

7 January 2021

Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900280-0

7 January 2021

Conserved structures and diversity of functions of RNA-binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900280-0

7 January 2021

Transcriptional regulation of multigene loci: multilevel control

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900280-0

7 January 2021

Strong conservation of non-coding sequences during vertebrates evolution: potential involvement in post-transcriptional regulation of gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900280-0

7 January 2021

eIF4G: a multipurpose ribosome adapter?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900280-0

7 January 2021

Both the 5' and 3' noncoding regions of the thyrotropin receptor messenger ribonucleic acid influence the level of receptor protein expression in transfected mamalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900280-0

7 January 2021

Co-operation of the 5' and 3' untranslated regions of ornithine decarboxylase mRNA and inhibitory role of its 3' untranslated region in regulating the translational efficiency of hybrid RNA species via cellular factor

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900280-0

7 January 2021

Less hype, more biology needed for gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900280-0

7 January 2021

High-level beta-globin expression after retroviral transfer of locus activation region-containing human beta-globin gene derivatives into murine erythroleukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900280-0

7 January 2021

Concepts and strategies for human gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900280-0

7 January 2021

Viral vectors for gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900280-0

7 January 2021

Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900280-0

7 January 2021

10.1016/S0169-328X(98)00280-0

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018